Intercept Pharmaceuticals, Inc. ICPT announced that it has formally notified the European Medicines Agency (“EMA”) of its decision to withdraw its marketing authorization application (MAA) for ...
Intercept Pharmaceuticals said on Thursday it would resubmit its application for nonalcoholic steatohepatitis (NASH) treatment to the U.S. Food and Drug Administration based on new interim analysis of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果